Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision tag was updated to v3.5.4, signaling a new release for the page. There are no detected user-facing content changes associated with this update.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThree new update dates were added to the study record's history in April 2026, and three older update dates from February and March 2026 were removed. The changes reflect administrative updates to the record rather than alterations to the study design, eligibility criteria, or results.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a maintenance or technical release without altering the displayed clinical study information.SummaryDifference0.0%

- Check46 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page shows administrative revision updates including a new revision (v3.5.0) with recent update dates (2026-02-26, 2026-03-18). The previous revision history (v3.4.3) and its dates appear to have been removed.SummaryDifference0.2%

- Check89 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.